Aptose Biosciences
APTO
#10464
Rank
NZ$7.56 M
Marketcap
NZ$2.96
Share price
0.00%
Change (1 day)
764.89%
Change (1 year)

Aptose Biosciences (APTO) - Cash on Hand

Cash on Hand as of March 2025 : NZ$8.14 Million

According to Aptose Biosciences's latest financial reports the company has NZ$8.14 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aptose Biosciences - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$14.62 M-80.22%
2022-12-31NZ$73.96 M-36.15%
2021-12-31NZ$0.11 B-31.71%
2020-12-31NZ$0.16 B17.05%
2019-12-31NZ$0.14 B517.62%
2018-12-31NZ$23.46 M45.81%
2017-12-31NZ$16.09 M40.39%
2016-12-31NZ$11.46 M-45.02%
2015-12-31NZ$20.84 M
2014-05-31NZ$32.97 M4106.02%
2013-05-31NZ$0.78 M90.23%
2012-05-31NZ$0.41 M-63.52%
2011-05-31NZ$1.12 M-11.68%
2010-05-31NZ$1.27 M-84.57%
2009-05-31NZ$8.29 M-31.52%
2008-05-31NZ$12.1 M11.14%
2007-05-31NZ$10.89 M-9.4%
2006-05-31NZ$12.02 M-50.64%
2005-05-31NZ$24.36 M-21.84%
2004-05-31NZ$31.17 M-1.69%
2003-05-31NZ$31.7 M-39.17%
2002-05-31NZ$52.11 M-31.57%
2001-05-31NZ$76.16 M-7.53%
2000-05-31NZ$82.37 M4892.53%
1999-05-31NZ$1.64 M-70.49%
1998-05-31NZ$5.59 M-44.78%
1997-05-31NZ$10.12 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Advaxis
ADXS
NZ$8.45 M 3.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
NZ$0.20 B 2,380.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
NZ$1.04 B 12,783.72%๐Ÿ‡บ๐Ÿ‡ธ USA